Artikel mit Open-Access-Mandaten - Justin StebbingWeitere Informationen
Nicht verfügbar: 48
Prüfen
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ...
The lancet oncology 15 (4), 406-414, 2014
Mandate: Cancer Research UK, UK Medical Research Council, National Institute for …
Prüfen
A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI)
DJ Pinato, J Stebbing, M Ishizuka, SA Khan, HS Wasan, BV North, ...
Journal of hepatology 57 (5), 1013-1020, 2012
Mandate: Cancer Research UK
Prüfen
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2 …
M Pestrin, S Bessi, F Puglisi, AM Minisini, G Masci, N Battelli, A Ravaioli, ...
Breast cancer research and treatment 134, 283-289, 2012
Mandate: Cancer Research UK
Prüfen
A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib
L Peng, K Xiao, S Ottaviani, J Stebbing, YJ Wang
Expert Opinion on Drug Safety 19 (11), 1505-1511, 2020
Mandate: National Institute for Health Research, UK
Prüfen
Claudin-1 as a promoter of EMT in hepatocellular carcinoma
J Stebbing, A Filipović, G Giamas
Oncogene 32 (41), 4871-4872, 2013
Mandate: Cancer Research UK
Prüfen
Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis
R Ramaswami, MD Villarreal, DM Pitta, JS Carpenter, J Stebbing, ...
Breast cancer research and treatment 152, 231-237, 2015
Mandate: Cancer Research UK, National Institute for Health Research, UK
Prüfen
The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis
J Krell, AE Frampton, J Jacob, L Pellegrino, L Roca-Alonso, D Zeloof, ...
Molecular diagnosis & therapy 16, 167-172, 2012
Mandate: Cancer Research UK
Prüfen
The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β1
Y Xu, H Zhang, LC Lit, A Grothey, M Athanasiadou, M Kiritsi, Y Lombardo, ...
Science signaling 7 (330), ra58-ra58, 2014
Mandate: Cancer Research UK, UK Medical Research Council, National Institute for …
Prüfen
The role of pseudokinases in cancer
H Zhang, A Photiou, A Grothey, J Stebbing, G Giamas
Cellular signalling 24 (6), 1173-1184, 2012
Mandate: Cancer Research UK
Prüfen
The impact of adjuvant chemotherapy timing on overall survival following colorectal cancer resection
S Nachiappan, A Askari, R Mamidanna, A Munasinghe, A Currie, ...
European Journal of Surgical Oncology (EJSO) 41 (12), 1636-1644, 2015
Mandate: Cancer Research UK, National Institute for Health Research, UK
Prüfen
Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer
JA Shaw, J Brown, RC Coombes, J Jacob, R Payne, B Lee, K Page, ...
Biomarkers in medicine 5 (1), 87-91, 2011
Mandate: Cancer Research UK
Prüfen
LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5
J Jacob, R Favicchio, N Karimian, M Mehrabi, V Harding, L Castellano, ...
Cancer letters 372 (1), 137-146, 2016
Mandate: Cancer Research UK, UK Medical Research Council, National Institute for …
Prüfen
Gene of the month: Axl
M Brown, JRM Black, R Sharma, J Stebbing, DJ Pinato
Journal of clinical pathology 69 (5), 391-397, 2016
Mandate: Cancer Research UK, Worldwide Cancer Research, UK
Prüfen
The p53 miRNA interactome and its potential role in the cancer clinic
J Krell, AE Frampton, T Colombo, TMH Gall, A De Giorgio, V Harding, ...
Epigenomics 5 (4), 417-428, 2013
Mandate: Cancer Research UK, UK Medical Research Council
Prüfen
Biological basis of [11C] choline-positron emission tomography in patients with breast cancer: comparison with [: 18: F] fluorothymidine positron emission tomography
KB Contractor, LM Kenny, J Stebbing, A Challapalli, A Al-Nahhas, ...
Nuclear medicine communications 32 (11), 997-1004, 2011
Mandate: Cancer Research UK
Prüfen
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
Y Jin, H Bao, X Le, X Fan, M Tang, X Shi, J Zhao, J Yan, Y Xu, K Quek, ...
Oncogene 39 (9), 1846-1859, 2020
Mandate: National Natural Science Foundation of China, National Institute for Health …
Prüfen
Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer
H Alshaker, Q Wang, AE Frampton, J Krell, J Waxman, M Winkler, ...
Breast cancer research and treatment 149, 59-67, 2015
Mandate: Cancer Research UK, UK Medical Research Council, National Institute for …
Prüfen
The emerging harm of antioxidants in carcinogenesis
C Hart, R Cohen, M Norwood, J Stebbing
Future Oncology 8 (5), 535-548, 2012
Mandate: Cancer Research UK
Prüfen
Monitoring Early Response to Taxane Therapy in Advanced Breast Cancer with Circulating Tumor Cells and [18F] 3´-deoxy-3´-Fluorothymidine PET: A Pilot Study
K Contractor, EO Aboagye, J Jacob, A Challapalli, RC Coombes, ...
Biomarkers in Medicine 6 (2), 231-233, 2012
Mandate: Cancer Research UK
Prüfen
TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition
DJ Pinato, S Chowdhury, J Stebbing
Oncogene 35 (21), 2684-2686, 2016
Mandate: Cancer Research UK, UK Medical Research Council, National Institute for …
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt